Levocetirizine
CAS No. 130018-77-8
Levocetirizine ( Levocetirizine | Xarlin | Xusal )
产品货号. M11207 CAS No. 130018-77-8
Levocetirizine 是一种 Histamine-1 Receptor Antagonist。左西替利嗪的作用机制是作为组胺 H1 受体拮抗剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥316 | 有现货 |
|
| 10MG | ¥558 | 有现货 |
|
| 25MG | ¥781 | 有现货 |
|
| 50MG | ¥921 | 有现货 |
|
| 100MG | ¥1669 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥268 | 有现货 |
|
生物学信息
-
产品名称Levocetirizine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Levocetirizine 是一种 Histamine-1 Receptor Antagonist。左西替利嗪的作用机制是作为组胺 H1 受体拮抗剂。
-
产品描述Levocetirizine is a Histamine-1 Receptor Antagonist. The mechanism of action of levocetirizine is as a Histamine H1 Receptor Antagonist. (In Vivo):Levocetirizine (0.4 mg/kg; oral administration; male Sprague-Dawley rats) treatment shows that the Cmax, AUC0-t, AUC0-∞ and t1/2 are 0.34 μg/mL, 3.26 μg h/mL, 3.67 μg h/mL and 2.34 hours, respectively in Sprague-Dawley rats.
-
体外实验——
-
体内实验Levocetirizine (0.4 mg/kg; oral administration; male Sprague-Dawley rats) treatment shows that the Cmax, AUC0-t , AUC0-∞ and t1/2 are 0.34 μg/mL, 3.26 μg h/mL, 3.67 μg h/mL and 2.34 hours, respectively in Sprague-Dawley rats. Animal Model:30 male Sprague-Dawley rats (8 weeks old; 200-250 g) Dosage:0.4 mg/kg Administration:Oral administration (Pharmacokinetic Analysis)Result:The Cmax, AUC0-t , AUC0-∞ and t1/2 were 0.34 μg/mL, 3.26 μg h/mL, 3.67 μg h/mL and 2.34 hours, respectively.
-
同义词Levocetirizine | Xarlin | Xusal
-
通路GPCR/G Protein
-
靶点Histamine Receptor
-
受体H1 receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number130018-77-8
-
分子量388.89
-
分子式C21H25ClN2O3
-
纯度>98% (HPLC)
-
溶解度Soluble in DMSO
-
SMILESOC(=O)COCCN1CCN(CC1)[C@H](c2ccccc2)c3ccc(Cl)cc3
-
化学全称Acetic acid, (2-(4-((R)-(4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Pasquali M, et al. Clin Exp Allergy. 2006 Sep;36(9):1161-7.
021-51111890
购物车()
sales@molnova.cn

